Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab and PDT in exudative AMD
NCT00684853Phase 2Unknown
- Sponsor
- Federal University of São Paulo
- Start
- Nov 2007
- Primary completion
- May 2008
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of verteporfin in exudative age-related macular degeneration, sponsored by Federal University of São Paulo. Status: unknown.
02
Drugs
verteporfin
03
Conditions
exudative age-related macular degeneration
Beyond the preview
Go deeper on NCT00684853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00684853.